Copyright Reports & Markets. All rights reserved.

Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019

Buy now

Table of Contents

    List of Tables

      List of Figures

        Report Guidance

          GlobalData Clinical Trials Report Coverage

            Clinical Trials by Region

              Clinical Trials and Average Enrollment by Country

                Top Five Countries Contributing to Clinical Trials in Asia-Pacific

                  Top Five Countries Contributing to Clinical Trials in Europe

                    Top Countries Contributing to Clinical Trials in North America

                      Top Countries Contributing to Clinical Trials in Middle East and Africa

                        Top Countries Contributing to Clinical Trials in Central and South America

                          Clinical Trials by G7 Countries: Proportion of Pancreatic Ductal Adenocarcinoma to Oncology Clinical Trials

                            Clinical Trials by Phase in G7 Countries

                              Clinical Trials in G7 Countries by Trial Status

                                Clinical Trials by E7 Countries: Proportion of Pancreatic Ductal Adenocarcinoma to Oncology Clinical Trials

                                  Clinical Trials by Phase in E7 Countries

                                    Clinical Trials in E7 Countries by Trial Status

                                      Clinical Trials by Phase

                                        In Progress Trials by Phase

                                          Clinical Trials by Trial Status

                                            Clinical Trials by End Point Status

                                              Subjects Recruited Over a Period of Time

                                                Clinical Trials by Sponsor Type

                                                  Prominent Sponsors

                                                    Top Companies Participating in Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials

                                                      Prominent Drugs

                                                        Latest Clinical Trials News on Pancreatic Ductal Adenocarcinoma

                                                          Nov 06, 2019: Oncolytics Biotech announces publication of positive REO 024 study results for Pelareorep in combination with Keytruda in patients with Advanced Pancreatic Adenocarcinoma

                                                            Nov 05, 2019: Gritstone Oncology announces data on novel shared tumor-specific neoantigens identified by its EDGE platform and contained within its SLATE Immunotherapy

                                                              Oct 15, 2019: Oncolytics Biotech presents clinical data highlighting the effectiveness of intravenous delivery to and replication of Pelareorep in tumors

                                                                Clinical Trial Profile Snapshots

                                                                  Appendix

                                                                    Abbreviations

                                                                      Definitions

                                                                        Research Methodology

                                                                          Secondary Research

                                                                            About GlobalData

                                                                              Contact Us

                                                                                Disclaimer

                                                                                  Source

                                                                                  Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019

                                                                                  Summary

                                                                                  GlobalData's clinical trial report, “Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Pancreatic Ductal Adenocarcinoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Ductal Adenocarcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

                                                                                  The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

                                                                                  Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

                                                                                  Scope

                                                                                  - The report provides a snapshot of the global clinical trials landscape
                                                                                  - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
                                                                                  - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
                                                                                  - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
                                                                                  - The Report provides enrollment trends for the past five years
                                                                                  - Report provides latest news for the past three months

                                                                                  Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

                                                                                  Reasons to buy

                                                                                  - Assists in formulating key business strategies with regards to investment
                                                                                  - Helps in identifying prominent locations for conducting clinical trials which saves time and cost
                                                                                  - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
                                                                                  - Supports understanding of trials count and enrollment trends by country in global therapeutics market
                                                                                  - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
                                                                                  - Facilitates clinical trial assessment of the indication on a global, regional and country level

                                                                                  Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

                                                                                  Buy now